Completed NA INTERVENTIONAL NCT00292799

An RCT of Metformin Vs Orlistat in Obese Anovulatory Women

A Randomised Controlled Clinical Trial of Metformin Versus Orlistat for the Management of Obese Anovulatory Women.

Sponsor: Hoffmann-La Roche

Updated 6 times since 2017 Last updated: Sep 21, 2021 Started: Feb 28, 2006 Primary completion: Feb 29, 2008 Completion: Feb 29, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00292799, this NA trial focuses on Anovulation and Obesity and remains completed. Sponsored by Hoffmann-La Roche, it has been updated 6 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Oct 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Oct 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hoffmann-La Roche
Sheffield Teaching Hospitals NHS Foundation Trust

Data source: Sheffield Teaching Hospitals NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sheffield, United Kingdom